NORML
MARCH 23, 2020
For example, one recent CBD provider recently received warning letters from the US Food and Drug Administration and the Federal Trade Commission for improperly marketing the agent as a key component of its COVID-19 prevention package. A greater discussion of these cannabis safety guidelines are available from NORML here.). ”
Cannabis Law Report
JANUARY 31, 2022
Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin. At this time, Numinus Bioscience said that it is prepared to supply psilocybin in whole mushroom form, through three packaged doses equivalent to 10, 15, and 25mg of psilocybin.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
MARCH 20, 2024
Furthermore, changes to testing and labeling requirements aim to uphold product quality and safety standards, providing patients with confidence in the products they receive from licensed dispensaries. Recent advancements include the expansion of qualifying medical conditions to ensure that more patients can benefit from cannabis therapy.
SpeedWeed
MAY 1, 2021
These products are often sold in packages of 100mg per edible for microdosing, or one gram per gummy for full-on psychedelic exploration. And since these products are illegal, there are no regulations ensuring their safety. A simple web search will turn up dozens of websites where you can score some of these exciting new gummies.
MMJ Recs
MARCH 2, 2024
Additionally, adhering to dispensary policies on product handling and consumption promotes harmony and safety. Ohio Cannabis Dispensary Regulations Dispensaries must adhere to strict regulations set forth by the Ohio Medical Marijuana Control Program to ensure compliance and patient safety.
The Joint Blog
AUGUST 8, 2023
Despite its legality, there are concerns about the safety and regulation of delta-8 THC products. There have been reports of adverse events related to the consumption of these products, particularly among children, who may mistake them for regular snacks due to similar packaging designs.
Cannabis Law Report
SEPTEMBER 15, 2021
This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans.
Expert insights. Personalized for you.
345 
Let's personalize your content